This Senator Just Blasted His GOP Colleagues for Ignoring the Opioid Epidemic

”If this becomes law, there is no Narcan for Medicaid. Once it’s cut by Trumpcare, it is dead.”

Sen. Ed Markey (D-Mass.) took to the Senate floor Monday night to blast his Republican colleagues for attempting to pass a health care bill that, amid a spiraling nationwide opioid epidemic, could eliminate insurance coverage for thousands of Americans that depend on it for addiction treatment. Markey pointed to the GOP’s efforts to cut Medicaid funding as particularly harmful for individuals dealing with an opioid addiction (the House’s health care bill included $834 billion in reductions to Medicaid spending).

“If this becomes law, there is no Narcan for Medicaid,” Markey said, referring to the brand name for naloxone, the overdose reversal medication. “Once it’s cut by Trumpcare, it is dead. Those devastating cuts would grind the progress we’ve made in expanding access to opioid treatment to a screeching halt and kick people currently in treatment to the curb.”

Senate Republicans are working on their bill to repeal Obamacare behind closed doors, so the details of how it would effect drug users in recovery are unknown. But an estimated 2.8 million Americans with a substance abuse disorder, including 220,000 who are addicted to opioids, would lose some or all of their insurance coverage if Obamacare is repealed, according to an analysis by researchers Richard Frank of Harvard Medical School and Sherry Glied of New York University. The Congressional Budget Office found that if a version of Trumpcare that passed the House last month became law, addiction treatment services “could increase by thousands of dollars in a given year” for those who aren’t covered by insurance through their employers.

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be done—that we hope you'll agree is worth supporting.

payment methods

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be done—that we hope you’ll agree is worth supporting.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate